- Home
- AUPH vs OPEN Comparison
AUPH vs OPEN Comparison
Compare AUPH & OPEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- OPEN
- Stock Information
- Founded
- AUPH 1993
- OPEN 2014
- Country
- AUPH Canada
- OPEN United States
- Employees
- AUPH N/A
- OPEN N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- OPEN Real Estate
- Sector
- AUPH Health Care
- OPEN Finance
- Exchange
- AUPH Nasdaq
- OPEN Nasdaq
- Market Cap
- AUPH 1.1B
- OPEN N/A
- IPO Year
- AUPH 1999
- OPEN N/A
- Fundamental
- Price
- AUPH $8.05
- OPEN $0.96
- Analyst Decision
- AUPH Strong Buy
- OPEN Hold
- Analyst Count
- AUPH 2
- OPEN 5
- Target Price
- AUPH $11.50
- OPEN $1.70
- AVG Volume (30 Days)
- AUPH 1.4M
- OPEN 42.5M
- Earning Date
- AUPH 05-01-2025
- OPEN 05-01-2025
- Dividend Yield
- AUPH N/A
- OPEN N/A
- EPS Growth
- AUPH N/A
- OPEN N/A
- EPS
- AUPH 0.04
- OPEN N/A
- Revenue
- AUPH $235,133,000.00
- OPEN $5,153,000,000.00
- Revenue This Year
- AUPH $11.86
- OPEN $3.84
- Revenue Next Year
- AUPH $24.96
- OPEN $21.51
- P/E Ratio
- AUPH $204.75
- OPEN N/A
- Revenue Growth
- AUPH 33.97
- OPEN N/A
- 52 Week Low
- AUPH $4.71
- OPEN $0.95
- 52 Week High
- AUPH $10.67
- OPEN $3.09
- Technical
- Relative Strength Index (RSI)
- AUPH 45.28
- OPEN 29.59
- Support Level
- AUPH $7.93
- OPEN $0.96
- Resistance Level
- AUPH $8.73
- OPEN $1.27
- Average True Range (ATR)
- AUPH 0.23
- OPEN 0.08
- MACD
- AUPH -0.05
- OPEN -0.01
- Stochastic Oscillator
- AUPH 20.00
- OPEN 4.53
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.